Related Experiment Video
Updated: Apr 23, 2026

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
HDAC4 blocks autophagy to trigger podocyte injury: non-epigenetic action in diabetic nephropathy
1Department of Cellular Biology and Anatomy, Medical College of Georgia, Georgia Regents University and Charlie Norwood Veterans Affairs Medical Center, Augusta, Georgia, USA.
Abstract:
Histone deacetylases (HDACs) have been implicated in the pathogenesis of kidney diseases including diabetic nephropathy (DN); however, the mechanism is poorly understood. Wang et al. unravel the changes in expression of various HDACs in DN and demonstrate that HDAC4 specifically contributes to podocyte injury in DN. HDAC4 deacetylates STAT1 to suppress autophagy, an essential cellular process for the function and viability of podocytes. The development of HDAC isoform-specific inhibitors may provide efficacious therapeutics for DN and related renal diseases.
Insights
Histone deacetylases (HDACs) contribute to diabetic nephropathy (DN) kidney disease. Specifically, HDAC4 damages podocytes by suppressing essential autophagy, suggesting HDAC inhibitors as potential DN therapeutics.
Area of Science:
- Nephrology
- Molecular Biology
- Biochemistry
Background:
- Histone deacetylases (HDACs) are linked to kidney disease pathogenesis, but their specific roles, particularly in diabetic nephropathy (DN), remain unclear.
- Understanding the molecular mechanisms underlying podocyte injury in DN is crucial for developing targeted therapies.
Purpose of the Study:
- To investigate the expression patterns of various HDACs in diabetic nephropathy.
- To elucidate the specific role of HDAC4 in podocyte injury during DN.
- To determine the molecular mechanism by which HDAC4 affects podocyte function in DN.
Main Methods:
- Analysis of HDAC expression in DN models.
- Experimental manipulation of HDAC4 levels in podocytes.
- Assessment of autophagy markers and STAT1 acetylation.
- Evaluation of podocyte viability and function.
Main Results:
- Wang et al. identified specific changes in HDAC expression profiles in DN.
- HDAC4 was found to be a key contributor to podocyte injury in DN.
- HDAC4 was shown to deacetylate STAT1, leading to the suppression of autophagy.
- Suppressed autophagy was directly linked to impaired podocyte function and viability.
Conclusions:
- HDAC4 plays a critical role in DN pathogenesis by inhibiting autophagy through STAT1 deacetylation.
- Targeting HDAC4 or related pathways could offer a novel therapeutic strategy for DN.
- Development of HDAC isoform-specific inhibitors may provide effective treatments for DN and other renal diseases.
More Related Videos
Related Concept Videos
Diabetic Nephropathy
Diabetic Neuropathy
Diabetic Retinopathy
Type I Diabetes II: Pathophysiology
Autophagy
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...

